Intraocular Lens Injectors Market Size & Share, by Product Type (Preloaded, Single Use, Reusable, High Diopter Intraocular Lens); Technology Type (Manual, Electric); Tip Incision Size (1.8mm, 2.0mm, 2.2mm, 2.4mm, 2.6mm); Application (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Eye Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Reports 2024-2036

  • Report ID: 6032
  • Published Date: May 15, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Intraocular Lens Injectors Market size was over USD 4.30 Billion in 2023 and is expected to reach USD 6.21 Billion by the end of 2036, growing at around 3.10% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of intraocular lens injectors is evaluated at USD 4.45 Billion.

This growth of the intraocular lens injectors market is assessed to be encouraged by the growing prevalence of cataracts. As per the estimation of the World Health Organization, above 2.2 billion individuals are suffering from near or distant vision impairment. Out of these numbers, over 1 billion people are set to have cataracts. Hence, in order to insert the folded lens in the patient's eyes a tool is needed further to reduce the patient's trauma during surgery. As a result, intraocular lens is considered to be the best tool in cataract surgery. 

Intraocular Lens Injectors Market-min
Get more information on this report: Request Free Sample PDF

Intraocular Lens Injectors Market: Growth Drivers and Challenges

Growth Drivers

  • Growing prevalence of eye disease among the geriatric population - As per WHO, the geriatric population aged above 60 is foreseen to reach 2.1 billion by 2050.  Cataracts are the most prevalent form among all the eye diseases that affect old people due to which the utilization of steroids is also growing among them.

    This is because elder people face several heart and kidney problems along with a fall in energy levels. Hence, steroids are assessed to tackle this issue and boost the energy level in them. However, long-term use of steroids is considered to be a major factor for the increasing eye problems among them.
  • Surging government initiatives - Governments across the globe are launching various initiatives regarding eye disease among people. Further, they are also holding campaigns to treat patients with eye diseases. As a result, more people are becoming aware about the eye disorders, and their treatment which includes surgeries for which intraocular lens injectors are required.

    In 2022, the Love Your Eyes campaign was launched by the International Agency for the Prevention of Blindness (IAPB) which observed over 19 parliament screenings, close to 6 million pledges from consumers, approximately 11,345 media pieces, and about 541 million media impressions. Furthermore, this campaign is set to focus on workplace eye conditions.
  • Increasing scope for the enhancement of intraocular lens injectors - The healthcare sector is being significantly influenced by advancements in technology. Using AI is one such advancement that has created great scope for intraocular lens injectors market expansion.

    For instance, the researchers have concluded that in contrast to the manual procedure of prediction, AI may enhance the accuracy of estimating IOL size and if it is suitable for high myopic patients. Some of the instances of AI based prediction systems include the Hill-radial basis function (RBF) formula and the Kane formula which have further earned huge importance in recent years.
  • Increasing cases of myopia - Since the outrage of COVID-19, the utilization of mobile phones has increased notably leading to multiple eye illnesses. Presently, about 5 billion individuals are utilizing smartphones, as it has become a necessary part of everyday life.

    However, this rise in exposure to screens has encouraged a rise in cases of myopia and the use of contact lens. As per the International Myopia Institute, nearly 50% of the world’s population will be myopic by 2050.


  • Growing price of intraocular lens - Unconventional IOL injector designs, and limited competitors are also influencing the price of this product. This is considered to be the biggest hindrance in low-income regions. Furthermore, limited access to advanced IOL technologies is also projected to restrict the market revenue.
  • Lack of skilled workers to handle the lens injectors - With the growing enhancement of technology, very few workers are able to manage them efficiently. In addition, the extra cost is required to train the employees, thus, the intraocular lens injectors market might suffer loss in the future.

Intraocular Lens Injectors Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

USD 4.30 Billion

Forecast Year Market Size (2036)

USD 6.21 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Intraocular Lens Injectors Segmentation

Product Type (Preloaded, Single Use, Reusable, High Diopter Intraocular Lens)

Preloaded intraocular lens injectors segment is poised to dominate over 40% intraocular lens injectors market share by 2036. This growth of the segment is set to be encouraged by growing cases of contamination by manual systems. Preloaded intraocular lens injectors reduce the possibility of endophthalmitis contamination.

Recently a study was conducted which stated that microbial causes from the prevalence of endophthalmitis are gram-positive bacteria which account for 85.1% of all isolates, whereas gram-negative bacteria accounted for 10.3% prevalence, and 4.6% of all cases were caused owing to fungi. Furthermore, it also reduces the prevalence of mistakes including loading the lens incorrectly.

Moreover, it has proven its efficiency to the nursing or technical staff by reducing the need to load the lenses, along with the surgeon. Also, it enables surgeons to preload several lenses and additionally limits the prevalence of delay once the lens is chosen. 

Technology Type (Manual, Electric)

By 2036, electric segment is estimated to dominate over 3.05% intraocular lens injectors market share. The major factor for the expansion of the segment is rising investment in digitalization in the healthcare sector. According to the World Bank over the past decade has spent over USD 4 billion on digital health which includes digital governance, infrastructure, and more.

Furthermore, the number of startups has successfully grown all across the world which is further offering digital health products for the patients. As a result, the electric segment of the intraocular lens injectors market is expected to observe growth.

Application (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Eye Research Institutes)

In intraocular lens injectors market, hospitals segment is poised to dominate over 49% revenue share by 2036. Various key players along with the government are also initiating the construction of advanced hospitals with the latest medical technologies further providing insurance coverage. This is leading to an increase in the number of hospitals with advanced technologies, for instance, in the year 2021, the globe had about 164,000 hospitals.

Our in-depth analysis of the global intraocular lens injectors market includes the following segments:




          Product Type

  • Preloaded Intraocular Lens Injectors
  • Single Use Intraocular Lens Injectors
  • Reusable Intraocular Lens Injectors
  • High Diopter Intraocular Lens


          Technology Type

  • Manual
  • Electric



          Tip Incision Size

  • 1.8mm
  • 2.0mm
  • 2.2mm
  • 2.4mm
  • 2.6mm




  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers
  • Eye Research Institutes

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Intraocular Lens Injectors Industry - Regional Synopsis

North American Market Statistics

North America intraocular lens injectors market is poised to dominate over 30% revenue share by 2036. The growing cases of ophthalmic disorders and the increasing number of ophthalmologists are also estimated to rise.

Furthermore, the consumption of alcohol has surged significantly which is further boosting the prevalence of diabetes which gives rise to diabetic retinopathy leading to vision loss and blindness in individuals. As per the Centers for Disease Control and Prevention indicates that over 9.6 million Americans were affected by diabetic retinopathy in 2021. 

US - Moreover, the US is predicted to have the presence of key players in the field of AI and machine learning which is further encouraging collaboration with the healthcare sector. Hence, this factor is estimated to boost the overall growth of the intraocular lens injectors industry in North America.

Canada - There have been rising government initiatives in the form of investment and campaigns to spread awareness regarding the prevalence of eye disease and they are also offering treatment for the same. The Government of Canada is foreseen to invest over USD 26 million from the Canadian Institutes of Health Research (CIHR) and partners to innovate integrated health care.

APAC Market Analysis

The Asia Pacific intraocular lens injectors market is expected to have notable growth in revenue which is set to reach USD 1.20 billion by the end of 2036. This rise is poised to be encouraged by the increasing urban population, and the associated several eye diseases. Over 2.2 billion individuals across the globe are currently residing in the region of Asia.  Moreover, it is anticipated that this estimation in urban regions of Asia might grow by 50%.

China - Additionally, the market in China is evaluated to have significant growth in the Asia Pacific region owing to the growing popularity and production of disposable intraocular lens injectors.  

Japan - The rising income of the employees in Japan is further encouraging their spending on eye surgery. 

Korea - The growing implantation of multifocal intraocular lens is estimated to have a significant influence on the intraocular lens injectors market in Korea. 

Research Nester
Intraocular Lens Injectors Market Size-min
Get more information on this report: Request Free Sample PDF

Companies Dominating the Intraocular Lens Injectors Landscape


    The intraocular lens injectors market consists of a number of key players. These key players are launching various strategic initiatives to expand their market position in the intraocular lens injectors industry.

    • SpyGlass Pharma
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Alcon
    • Bausch Health Companies, Inc.
    • Carl Zeiss AG
    • Johnson & Johnson Services, Inc.
    • The Cooper Companies, Inc.
    • EssilorLuxottica
    • Ziemer Ophthalmic Systems AG
    • Staar Surgical
    • Haag-Streit AG

In the News

  • SpyGlass Pharma announced 1-year follow-up information from a first-in-human study of 23 patients with glaucoma or ocular hypertension introduced with SpyGlass’ Intraocular Lens (IOL) based Drug Delivery Platform with bimatoprost during the time of cataract surgery. 
  • Alcon announced that it has launched Clareonfamily of intraocular lenses (IOLs) in the United States. Using Alcon’s most innovative IOL material, Clareon may deliver continuous visual outcomes and exceptional clarity that lasts.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 6032
  • Published Date: May 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of intraocular lens injectors was over USD 4.30 billion.

The market size for intraocular lens injectors is predicted to cross USD 6.21 billion by the end of 2036 expanding at a CAGR of 3.10% during the forecast period i.e., between 2024-2036.

The major players in the market are SpyGlass Pharma, Alcon, Bausch Health Companies, Inc., Carl Zeiss AG, and others.

The preloaded intraocular lens injectors segment is anticipated to garner a share of 40% during 2024-2036.

The North America intraocular lens injectors sector is poised to hold a 30% share by the end of 2036.
Intraocular Lens Injectors Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying